Facebook Linkedin RSS Twitter Youtube
Home 2023

CRISPR

FDA Approves Casgevy, the First CRISPR Therapy, for Sickle Cell Disease
Genome Editing

FDA Approves Casgevy, the First CRISPR Therapy, for Sickle Cell Disease

Base Editing Strategy for Spinal Muscular Atrophy Rescues Patient Fibroblasts, Reverses Mouse Pathology
Drug Discovery

Base Editing Strategy for Spinal Muscular Atrophy Rescues Patient Fibroblasts, Reverses Mouse Pathology

2023 Year in Review: An Exciting Moment in CRISPR-Land
Industry News

2023 Year in Review: An Exciting Moment in CRISPR-Land

2023 Year in Review: Business Developments
Industry News

2023 Year in Review: Business Developments

AstraZeneca, University of Cambridge Expand Functional Genomics Collaboration
Drug Discovery

AstraZeneca, University of Cambridge Expand Functional Genomics Collaboration

RoslinCT Will Manufacture World’s-First CRISPR-Based Therapy
Bioprocessing

RoslinCT Will Manufacture World’s-First CRISPR-Based Therapy

Cancer Shredder Utilizes CRISPR, Targets Glioblastoma
Cancer

Cancer Shredder Utilizes CRISPR, Targets Glioblastoma

Thousands of CRISPR Systems Uncovered with New Search Algorithm
Artificial Intelligence

Thousands of CRISPR Systems Uncovered with New Search Algorithm

“Transformer” Base Editor Safely and Durably Induces Fetal Hemoglobin in Human HSCs
Genome Editing

“Transformer” Base Editor Safely and Durably Induces Fetal Hemoglobin in Human HSCs

Alzheimer’s Risk Increased by Microglia Mutation
News

Alzheimer’s Risk Increased by Microglia Mutation

123...111Page 1 of 111
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.